Skip to main content

WELLS FARGO & COMPANY/MN

Position in ADCT — ADC Therapeutics SA

CIK 72971 SAN FRANCISCO, CA

Position in ADCT

as of Mar 31, 2026 · filed May 11, 2026
Position Value
$985,436
-$144,333 QoQ
Shares Held
262,783
-17.9% QoQ
Ownership
0.207%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
not a current holder
Holding Since
Mar 2021
15 quarters on record
Voting authority Sole 100% Shared 0% None 0%

Common Shares in ADCT Over Time

Shares Held

Position Value (USD)

Position in Drug Manufacturers - Specialty & Generic

Healthcare · as of Mar 31, 2026

WELLS FARGO & COMPANY/MN holds $924,794,490 across 59 Drug Manufacturers - Specialty & Generic names. ADCT ranks #22 (0.1% of the industry book) .

# Ticker Company Shares Value (USD) Open

All Filings in ADCT

Export CSV
15 filing rows on record
Report Date Value (USD) Shares
2026-03-31 $985,436 262,783
2025-12-31 $1,129,769 320,048
2025-09-30 $278,004 69,501
2025-06-30 $167,341 62,441
2025-03-31 $95,565 67,777
2024-12-31 $83,245 41,832
2024-09-30 $94,493 29,998
2024-06-30 $81,224 25,704
2022-09-30 $964 200
2022-06-30 $1,590 200
2022-03-31 $2,938 200
2021-12-31 $4,040 200
2021-09-30 $14,476 533
2021-06-30 $19,480 800
2021-03-31 $53,702 2,200